Log in or Sign up for Free to view tailored content for your specialty!
Practice Management News
Emory researchers developing visual tool to view effects of Alzheimer's, ASD on brain
Researchers at Emory University are developing a visual tool to view how conditions such as Alzheimer's disease and autism spectrum disorder affect the brain in real-time, the university announced in a press release.
Tool developed to predict dementia risk
A practical risk score tool has been developed to help people identify their potential risk for dementia, researchers reported in JAMA Network Open.
Log in or Sign up for Free to view tailored content for your specialty!
Excessive alcohol use accounts for one in eight deaths in US adults
Excessive alcohol use was attributed to 12.9% of deaths among Americans aged 20 to 64 years from 2015 to 2019, a new study revealed.
Teachers reported more depression, anxiety compared with other workers during pandemic
Teachers showed a significantly higher prevalence of negative mental health outcomes compared with health care and office workers during the COVID-19 pandemic, researchers reported in Educational Researcher.
Video: Alternate word use recommended for specific terms involving opioid use
In this video, Karen Werder, PhD, PMHNP-BC, PHN, assistant professor at the Sonoma State University School of Nursing, discussed a presentation she gave at the American Psychiatric Nurses Association Annual Conference.
FDA gives Investigational New Drug clearance for resistant depression treatment
Biomind Labs Inc. announced that the FDA has given the company Investigational New Drug clearance related to its new chemical entity, Triptax, for the treatment of treatment-resistant depression.
Video: Impact of language around opioid use disorder a key topic at APNA
In this video, Karen Werder, PhD, PMHNP-BC, PHN, assistant professor at the Sonoma State University School of Nursing, discussed a presentation she gave at the American Psychiatric Nurses Association Annual Conference.
Racial, ethnic disparities persist, increase in buprenorphine treatment
Racial and ethnic disparities in buprenorphine treatment duration increased from 2006 to 2020, but particularly more in recent years, researchers wrote in a research letter in JAMA Psychiatry.
Nonprofit announces $96M in funding for mental health, delirium, alcohol use research
The Patient-Centered Outcomes Research Institute has announced $96 million in funding for 18 new studies that will focus on mental health, delirium and adolescent alcohol use.
Mindfulness-based stress reduction noninferior to escitalopram for anxiety
Mindfulness-based stress reduction was found to be noninferior to escitalopram for the treatment of anxiety disorders, researchers reported in JAMA Psychiatry.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read